metformin has been researched along with abiraterone acetate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cathomas, R; Gillessen, S; Klingbiel, D; Manetsch, G; Mark, M; Mey, U; Pollak, M; Rothermundt, C; Strebel, R; von Moos, R; Winterhalder, R | 1 |
| O'Reilly, D | 1 |
| Armstrong, AJ; Carles, J; Chi, KN; de Bono, J; De Porre, P; Fizazi, K; Gillessen, S; Hu, P; Jones, RJ; Joshua, AM; Logothetis, CJ; Rathkopf, D; Ryan, CJ; Saad, F; Scher, HI; Smith, MR; Sternberg, CN; Tran, N; Wilson, BE | 1 |
2 trial(s) available for metformin and abiraterone acetate
| Article | Year |
|---|---|
Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Humans; Male; Metformin; Pilot Projects; Prostatic Neoplasms, Castration-Resistant; Survival Analysis; Treatment Outcome | 2019 |
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Castration; Disease-Free Survival; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metformin; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2022 |
1 other study(ies) available for metformin and abiraterone acetate
| Article | Year |
|---|---|
Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone
Topics: Abiraterone Acetate; Androstenes; Humans; Male; Metformin; Pilot Projects; Prostatic Neoplasms, Castration-Resistant | 2019 |